文献速递腹部MR

钆塞酸增强MRI特征对肝细胞癌微血管侵犯的预测价值

The role of gadoxetic acid-enhanced MRI features for predicting microvascular invasion in patients with hepatocellular carcinoma.
PubMed 文献 · Abdom Radiol (NY) · 2021-12-28

回顾性纳入134例肝切除术后病理确诊肝细胞癌患者,评估钆塞酸增强MRI的LI-RADS v2018及非LI-RADS特征对微血管侵犯的预测价值;晕状强化、镶嵌结构、肿瘤边缘不光滑、肝胆期瘤周低信号为独立预测因子,具备任一特征时敏感度93.2%、特异度71.1%。

要点

  • 肝胆期瘤周低信号预测微血管侵犯的OR为33.123,为四项特征中效应量最大者。
  • 具备晕状强化、镶嵌结构、肿瘤边缘不光滑、肝胆期瘤周低信号任一特征时,敏感度93.2%、特异度71.1%。
  • 肿瘤边缘不光滑OR为13.131,镶嵌结构OR为7.097,晕状强化OR为5.787。

核心结论

  • 晕状强化、镶嵌结构、肿瘤边缘不光滑、肝胆期瘤周低信号四项MRI特征可作为术前影像生物标志物预测高危肝细胞癌患者的微血管侵犯,具备任一特征时敏感度>90%。

研究设计与样本

  • 回顾性研究,纳入2018年10月至2020年12月134例肝切除术前接受钆塞酸增强MRI且术后病理确诊肝细胞癌的患者。
  • 由两名放射科医师评估术前LI-RADS v2018影像特征及非LI-RADS特征,采用逻辑回归模型筛选微血管侵犯的独立预测因子。

关键影像表现/征象

  • 晕状强化、镶嵌结构、肿瘤边缘不光滑、肝胆期瘤周低信号为微血管侵犯的独立预测因子。

诊断标准与关键数值

  • 晕状强化预测微血管侵犯的OR为5.787(95%CI 1.180, 28.369;p=0.030)。
  • 镶嵌结构预测微血管侵犯的OR为7.097(95%CI 1.299, 38.783;p=0.024)。
  • 肿瘤边缘不光滑预测微血管侵犯的OR为13.131(95%CI 3.950, 43.649;p<0.001)。
  • 肝胆期瘤周低信号预测微血管侵犯的OR为33.123(95%CI 2.897, 378.688;p=0.005)。
  • 四项特征具备任一项时预测微血管侵犯的敏感度为93.2%(41/44),特异度为71.1%(64/90)。

临床应用与阅片要点

  • 阅片时可关注晕状强化、镶嵌结构、肿瘤边缘不光滑及肝胆期瘤周低信号四项特征,具备任一特征时提示微血管侵犯风险较高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the predictive value of gadoxetic acid-enhanced MRI features (focused on Liver Imaging Reporting and Data System (LI-RADS) v2018 features and non-LI-RADS imaging features) for microvascular invasion (MVI) of hepatocellular carcinoma (HCC).

METHODS: From October 2018 to December 2020, 134 patients who underwent gadoxetic acid-enhanced MRI with a pathological diagnosis of HCC after hepatectomy were enrolled in this retrospective study. Two radiologists assessed the pre-hepatectomy LI-RADS v2018 imaging features and non-LI-RADS features to identify independent predictors of MVI of HCC with a logistic regression model.

RESULTS: Four MRI features were found to be independent predictors of MVI: corona enhancement [odds ratio (OR) 5.787; 95% confidence interval (CI) 1.180, 28.369; p = 0.030], mosaic architecture (OR 7.097; 95% CI 1.299, 38.783; p = 0.024), nonsmooth tumor margin (OR 13.131; 95% CI 3.950, 43.649; p < 0.001), and peritumoral hypointensity on hepatobiliary phase (HBP) (OR 33.123; 95% CI 2.897, 378.688; p = 0.005). When one of four imaging features was present, the sensitivity was 93.2% (41/44), and the specificity was 71.1% (64/90).

CONCLUSION: The four imaging features including corona enhancement, mosaic architecture, nonsmooth tumor margin, and peritumoral hypointensity on HBP can be used as preoperative imaging biomarkers for predicting MVI in patients at high risk for HCC. When one of the four imaging features is present, MVI can be predicted with a sensitivity > 90%.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Yang, Han, Huang, et al. The role of gadoxetic acid-enhanced MRI features for predicting microvascular invasion in patients with hepatocellular carcinoma. Abdom Radiol (NY). 2021. PMID: 34962593. doi:10.1007/s00261-021-03392-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。